[Webinar] Maintaining Momentum: Applying Recent Regulatory Guidance in the Midst of the Coronavirus
COVID-19
We applaud and support the efforts of teams developing treatments for COVID-19. As a proven leader in regulatory affairs, we understand the challenges that come with crucial studies. We stand ready to help those working for answers to navigate complex regulatory issues.
Slider

Service Solutions

Cato Research, Your Reliable Partner

Cato Research (CATO) is an international regulatory and clinical contract research organization (CRO) that has been delivering successful outcomes for its clients since 1988. Through highly qualified and experienced personnel located in offices across North America, Europe, Israel, and South Africa, supported by strategic alliances with selected regional CROs, CATO offers tried-and-trusted international coverage.

CATO has the advantage of integrated regulatory, clinical, and scientific expertise. Our highly talented and experienced international team offers services from preclinical through IND (or equivalent), clinical development, and marketing approval to Phase 4 postmarketing research. Our track record includes successes across many different health products, including drugs, biologics, vaccines, cell therapies (including stem cells), nutriceuticals, medical foods, devices, and diagnostics. In terms of diseases and indications, CATO has been involved in a wide variety of projects with a dominant focus in oncology, neurology/CNS, and rare and orphan drug indications. This experience includes leadership of, and involvement in some of the most challenging and innovative products.

Therapeutic Expertise

What our Sponsors say about us...

“…We have no reservations

"...We have no reservations recommending CATO to other companies requiring assistance with the monitoring of all phases of clinical trials..."

- Global Pharma Co.

Cato Research - International Contract Research Organization | Research Triangle Park, Durham, North Carolina
2017-11-22T15:48:10-05:00

- Global Pharma Co.

"...We have no reservations recommending CATO to other companies requiring assistance with the monitoring of all phases of clinical trials..."

“…Cato was instrumental

"…Cato was instrumental in helping us with site identification, site qualification, supporting our regulatory submissions and identification of quality vendors in support of trial logistics.




They supported us regarding the IVRS system, monitoring central labs and build of lab kits. The collaboration between Cato and [OUR COMPANY] was excellent."

- Global Healthcare Company

Cato Research - International Contract Research Organization | Research Triangle Park, Durham, North Carolina
2017-11-22T15:49:15-05:00

- Global Healthcare Company

"…Cato was instrumental in helping us with site identification, site qualification, supporting our regulatory submissions and identification of quality vendors in support of trial logistics. They supported us regarding the IVRS system, monitoring central labs and build of lab kits. The collaboration between Cato and [OUR COMPANY] was excellent."
0
0
Cato Research - International Contract Research Organization | Research Triangle Park, Durham, North Carolina

Upcoming Events

No event found!
Load More

Cato Research Blog

  • New FDA Gudiances for August 2020 and Upcoming...
    by Cato Research on September 3, 2020 at 12:07 pm

    By Dieanira Erudaitius, PhD, RAC, Regulatory Scientist, Regulatory Affairs at CATO SMS    Special Interest Guidances/Information Date Posted Principles for Selecting, Developing, Modifying, and Adapting Patient-Reported Outcome Instruments for Use in Medical Device Evaluation: Draft Guidance for […]

  • New FDA Gudiances for July 2020 and Upcoming...
    by Cato Research on August 5, 2020 at 7:46 pm

      By Joshua Taylor, PhD, RAC, Director – Regulatory Affairs at CATO SMS    Special Interest Guidances/Information Date Posted Pediatric Study Plans: Content of and Process for Submitting Initial Pediatric Study Plans and Amended Initial Pediatric Study Plans – Final Guidance 31 Jul 2020 […]

Twitter @CatoResearch

LinkedIn Cato Research

Facebook @catoresearch

Searching for something else?